r2d2 Posted October 12, 2020 Report Share Posted October 12, 2020 Mallinckrodt Pharmaceuticals, facing billions of dollars in legal costs over its role in the nation's opiod crisis, filed for bankruptcy early Monday. The largest generic opioid manufacturer in the United States is losing battles on multiple fronts. A recent court decision could force Mallinckrodt to pay hundreds of millions of dollars in higher rebates to state Medicaid programs for its best-selling drugs. Last year, the Justice Department filed suit against the company, charging that it knowingly paid illegal kickbacks as part of an elaborate scheme to make millions of dollars and stick the American taxpayer with the bill. But the most expensive problem Mallinckrodt (MNK) faces are lawsuits charging it with helping to feed the nation's opiod crisis. In February, it reached an agreement in principle on a $1.6 billion settlement with attorneys general for 47 states and US territories. The company said it intends to use bankruptcy to "provide a fair, orderly, efficient and legally binding mechanism" that provides for an amended proposed opioid claims settlement and a financial restructuring that would settle its other legal woes. Quote Link to comment Share on other sites More sharing options...
DummyVariable Posted October 12, 2020 Report Share Posted October 12, 2020 MNK is the largest manufacturer of oxycodone and hydrocodone - both schedule 2 drugs iirc. Veetiki very big black market. Party drugs. Quote Link to comment Share on other sites More sharing options...
Maryadaramanna Posted October 12, 2020 Report Share Posted October 12, 2020 27 minutes ago, DummyVariable said: MNK is the largest manufacturer of oxycodone and hydrocodone - both schedule 2 drugs iirc. Veetiki very big black market. Party drugs. ok Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You can post now and register later. If you have an account, sign in now to post with your account.